Home › Non-Muscle Invasive Bladder Cancer › New York › Staten Island
Non-Muscle Invasive Bladder Cancer clinical trials in Staten Island, NY
4 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Staten Island (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RecruitingPhase 3
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi away
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RecruitingPhase 1
- MSK Monmouth, Middletown · 12 mi away
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
RecruitingPhase 3
- Memorial Sloan Kettering Monmouth (Consent Only), Middletown · 12 mi away
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
RecruitingPhase 1/2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi away
Non-Muscle Invasive Bladder Cancer trials in other cities
- Columbus, OH10 studies
- Dallas, TX10 studies
- New York City, NY10 studies
- Myrtle Beach, SC9 studies
- Edison, NJ9 studies
- Baltimore, MD8 studies
- Syracuse, NY8 studies
- Nashville, TN8 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
- Birmingham, AL7 studies
- Philadelphia, PA7 studies
Other studies in Staten Island
- Breast Cancer40 studies
- Non-Small Cell Lung Cancer19 studies
- Prostate Cancer16 studies
- Acute Myeloid Leukemia14 studies
- Multiple Myeloma13 studies
- Lung Cancer12 studies
- Bladder Cancer11 studies
- Cancer (all types)11 studies
- Endometrial Cancer11 studies
- Metastatic Cancer10 studies
- Ovarian Cancer9 studies
- Head and Neck Squamous Cell Carcinoma9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.